Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines

Drug combination therapies are common practice in the treatment of cancer. In this study, we evaluated the anticancer effects of myricetin (MYR), methyl eugenol (MEG) and cisplatin (CP) both separately as well as in combination against cervical cancer (HeLa) cells. To demonstrate whether MYR and MEG...

Full description

Saved in:
Bibliographic Details
Published in:Int J Clin Exp Pathol
Main Authors: Yi, Jin-Ling, Shi, Song, Shen, Yan-Li, Wang, Ling, Chen, Hai-Yan, Zhu, Jun, Ding, Yan
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396221/
https://ncbi.nlm.nih.gov/pubmed/25972998
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items